Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
about
Activation of human factor IX (Christmas factor)Deficiency of protein C in congenital thrombotic diseaseThree point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteinsExpression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.Thrombosis: its role and prevention in cardiovascular events-Part II.Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IXLymphoid procoagulant response to bacterial endotoxin in the rat.Immunoradiometric measurement of the factor VIII procoagulant antigen.Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.Combined functional and immunochemical analysis of normal and abnormal human factor X.A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism.Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.New methods in coagulation.Acquired antibody to factor XI in a patient with congenital factor XI deficiency.Cleavage and inactivation of Factor IX by granulocyte elastase.Suppression of CYP3A2 mRNA expression in the warfarin-resistant roof rat, Rattus rattus: possible involvement of cytochrome P450 in the warfarin resistance mechanism.
P2860
Q24594116-3D58FBC4-E1DD-4225-A9A4-98B5284C47A0Q24600822-EED487C0-F97D-44A8-A33A-3E889E9260FEQ28117874-66547671-07B7-4CB3-83C1-BF16F6A30C4AQ33739384-897C3EFD-2CA5-49B5-B438-D07B2BAC0483Q34109495-55337339-9939-41BE-9EE3-BBFE603A89ACQ34573791-1D6CE3A1-9431-491F-B3D5-61DAC02D6073Q34609944-CC982EF1-ED57-4CC9-8B1D-D1D99BE4EA02Q37031326-76AAE936-3D09-4B22-ADC1-349ECA978D77Q37033265-D37AC4F9-54A7-4FDD-83B1-DB92F0BDD87DQ37033453-2A4836A0-0E4D-4059-84C8-C75980B08B8CQ37042035-393A8FFA-A441-4E4A-A22C-54CC83CCEBABQ37360472-D77F85AF-47A5-46CE-8CA6-C4B6D91804D2Q37367046-512542BB-F083-41CC-AB17-79CDE9D2ABFCQ40219568-6A1A83F6-C5D9-4E73-943A-7E44C97D2AAEQ40681162-8EBC82A7-9EE7-4BFC-AE4F-B86D7C2E279FQ40682368-19C7FDCA-E941-44ED-AEEE-4677D2A8A786Q43725042-B21F189F-69B0-42AF-8435-ADC0D45F147E
P2860
Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1977
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factor IX antigen by radioimmu ...... therapy and with hemophilia B.
@en
Factor IX antigen by radioimmu ...... therapy and with hemophilia B.
@nl
type
label
Factor IX antigen by radioimmu ...... therapy and with hemophilia B.
@en
Factor IX antigen by radioimmu ...... therapy and with hemophilia B.
@nl
prefLabel
Factor IX antigen by radioimmu ...... therapy and with hemophilia B.
@en
Factor IX antigen by radioimmu ...... therapy and with hemophilia B.
@nl
P2860
P921
P356
P1476
Factor IX antigen by radioimmu ...... therapy and with hemophilia B.
@en
P2093
Thompson AR
P2860
P304
P356
10.1172/JCI108712
P407
P577
1977-05-01T00:00:00Z